The FDA: Doctors, Investigators, and Translational Research

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Characterization of investigators' approach to translational research: a qualitative study.

BACKGROUND Little is known about how investigators approach their research programs along the translational research continuum. Many consider the translational continuum to be linear, with research beginning at the bench and concluding with research at the bedside or in the community. We aimed to understand if translational investigators approach and view their research in this fashion. METHO...

متن کامل

Mentoring translational science investigators.

A PRIMARY MISSION OF THE NATIONAL INSTITUTES OF Health(NIH)istotrainthenextgenerationofclinical/ translational scientists. The NIH K-series training grantsare3to5-yearawards thatprovideprotected time (up to 75% salary support) and research funding (up to $50 000peryear)tonewinvestigatorsfollowingfellowshiptrainingtopreparethemforR01-levelfunding.ExamplesofKawards include individualawardssuchasK...

متن کامل

Education and training of clinical and translational study investigators and research coordinators: A competency-based approach

INTRODUCTION Training for the clinical research workforce does not sufficiently prepare workers for today's scientific complexity; deficiencies may be ameliorated with training. The Enhancing Clinical Research Professionals' Training and Qualifications developed competency standards for principal investigators and clinical research coordinators. METHODS Clinical and Translational Science Awar...

متن کامل

Biologics clinical trials, research, and FDA actions.

Hopes raised, hopes dashed — the last half of 2012 has seen plenty of both. Enthusiasm over a bumper crop of U.S. Food and Drug Administration approvals has been tempered by a long list of phase 3 trial disappointments. Oncology agents led the way, starting with two drugs being studied for the treatment of non-small cell lung cancer. The addition of Eli Lilly’s pemetrexed (Alimta) to a regimen ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Investigative Dermatology

سال: 2015

ISSN: 0022-202X

DOI: 10.1038/jid.2015.258